Cipla Ltd.
BSE: 500087 | NSE: CIPLA
Large Cap | Pharmaceuticals & Drugs
1426.80
-11.95 (-0.83%) Cipla - Quaterly Results
Date: 12-05-2023
The quarter ended March 2023 witnessed marginal change in the total revenue. The figure for the mentioned quarter is pegged at Rs. 38937.40 millions.The Company to register a -44.39% fall in the net profit for the quarter ended March 2023.A decline of 9194.90 millions was observed in the OP in the quarter ended March 2023 from 9415.70 millions on QoQ basis.
(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202303 | 202203 | % Var | 202303 | 202203 | % Var | 202303 | 202203 | % Var | |
| Sales | 38937.40 | 37345.90 | 4.26 | 157906.00 | 153808.20 | 2.66 | 157906.00 | 153808.20 | 2.66 |
| Other Income | 1197.10 | 3163.10 | -62.15 | 4567.90 | 6667.00 | -31.48 | 4567.90 | 6667.00 | -31.48 |
| PBIDT | 9194.90 | 9415.70 | -2.35 | 42493.70 | 43779.30 | -2.94 | 42493.70 | 43779.30 | -2.94 |
| Interest | 104.60 | 57.80 | 80.97 | 270.20 | 269.30 | 0.33 | 270.20 | 269.30 | 0.33 |
| PBDT | 7231.30 | 9357.90 | -22.73 | 40364.50 | 43510.00 | -7.23 | 40364.50 | 43510.00 | -7.23 |
| Depreciation | 1615.80 | 1367.20 | 18.18 | 5959.10 | 5466.20 | 9.02 | 5959.10 | 5466.20 | 9.02 |
| PBT | 5615.50 | 7990.70 | -29.72 | 34405.40 | 38043.80 | -9.56 | 34405.40 | 38043.80 | -9.56 |
| TAX | 2060.60 | 1598.60 | 28.90 | 9710.10 | 9218.00 | 5.34 | 9710.10 | 9218.00 | 5.34 |
| Deferred Tax | -385.80 | -0.50 | 77060.00 | -400.90 | -276.90 | 44.78 | -400.90 | -276.90 | 44.78 |
| PAT | 3554.90 | 6392.10 | -44.39 | 24695.30 | 28825.80 | -14.33 | 24695.30 | 28825.80 | -14.33 |
| Equity | 1614.30 | 1613.60 | 0.04 | 1614.30 | 1613.60 | 0.04 | 1614.30 | 1613.60 | 0.04 |
| PBIDTM(%) | 23.61 | 25.21 | -6.34 | 26.91 | 28.46 | -5.46 | 26.91 | 28.46 | -5.46 |